Log In Sign Up Premium
#1 AI Stock to Buy
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Economy
    • Industries
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Insider Trading Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Transcripts
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Investor Letters
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing · 30-day money back guarantee

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing

Unlock Now — $9.99
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘RA Capital Management’

Hedge Fund and Insider Trading News: Bobby Jain, Scott Bessent, Warren Buffett, Maverick Capital, Point72 Asset Management, Millennium Management, Citadel Investment Group, RA Capital Management, Arrow Electronics Inc (ARW), Palantir Technologies Inc (PLTR), and More

You may be concerned about the recent declines in AI stocks such as NVDA.

Keep Reading →

August 6 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: Bill Ackman, Marshall Wace LLP, Balyasny Asset Management, Bridgewater Associates, AQR Capital Management, RA Capital Management, Millennium Management, Lancaster Colony Corp (LANC), PBF Energy Inc (PBF), and More

Bill Ackman Seeks To Revive IPO With Sweeteners For Investors (Financial Times) Marshall Wace, Systematica Short National Express Owner Mobico (Financial News London) Balyasny Wants To Build An AI Equivalent Of A Senior Analyst.

Keep Reading →

August 29 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: David Tepper, Ray Dalio, RA Capital Management, Millennium Management, Biohaven Ltd (BHVN), EyePoint Pharmaceuticals Inc. (EYPT), and More

Billionaire Investor David Tepper Has 32% Of His Portfolio Invested In These 3 Incredible Artificial Intelligence (AI) Growth Stocks (The Motley Fool) Why ASX Investors Might Be About To Face The ‘Dalio Dilemma’ (AFR.

Keep Reading →

April 23 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: Ken Griffin, Jim Simons, Cliff Asness, ARK36, Three Arrows Capital, Plains All American Pipeline, L.P. (PAA), Tricida, Inc. (TCDA), and More

Jim Simons discussed why his hedge fund employs scientists instead of bankers, defended Warren Buffett's relevance in an age of supercomputers and algorithmic trading, and shared...

Keep Reading →

June 27 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: Millennium Management, RA Capital Management, Elliott Investment Management, Quantology Capital Management, QQM Fund Management, Akerna Corp (KERN), Alimentation Couche-Tard Inc (ANCUF), and More

Millennium Management sent a memo to staff telling them to disclose any personal trading in cryptocurrencies to the hedge fund giant’s compliance team.

Keep Reading →

October 11 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: John Paulson, Steve Cohen, RA Capital Management, Tiger Global Management, Norron Asset Management, Eastman Chemical Company (EMN), Ipsidy Inc (AUID), and More

Ever since John Paulson bet against the U.S. housing market more than a decade ago, people keep asking him about his next big trade.

Keep Reading →

August 30 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: Russell Clark, Jason Karp, Viking Global Investors, Elliott Management, Mudrick Capital Management, UMH Properties, Inc (UMH), Titan Machinery Inc. (TITN), and More

Elliott Management Corp.

Keep Reading →

June 2 - Hedge Funds, Insider Trading

Hedge Fund and Insider Trading News: Bill Ackman, Steven A. Cohen, Tom Steyer, RA Capital Management, Healthequity Inc (HQY), Tel-Instrument Electronics Corp. (TIKK), and More

Bill Ackman’s publicly-traded Pershing Square Holdings Ltd. has an activist of its own.

Keep Reading →

July 16 - Hedge Funds, Insider Trading

RA Capital Management Bets Another $20 Million On Kala Pharmaceuticals Inc.

Peter Kolchinsky's RA Capital purchased $20 million of Kala Pharmaceuticals Inc. (KALA) shares.

Keep Reading →

October 8 - Hedge Funds, Insider Trading, News

This Biotech Investor’s Picks Returned 31% in Q1; Here Are Its New Bets

Peter Kolchinsky is one of the best biotech investors and many of his stock picks generate strong returns.

Keep Reading →

June 12 - Hedge Funds, News

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex.

Keep Reading →

May 1 - Hedge Funds, News

13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

April 3 - Hedge Funds

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

March 28 - Hedge Funds

13D Filing: RA Capital Management and Solid Biosciences Inc (SLDB)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

February 12 - Hedge Funds

Big Insider Buying at Hot IPO Solid Biosciences (SLDB), Range Resources (RRC) and General Electric (GE)

With the stock market having been battered in recent days and fears that a large correction may be starting to pick up steam becoming more pronounced, investors are now in a position...

Keep Reading →

February 5 - Hedge Funds, Insider Trading, Market Movers, News

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

January 26 - Hedge Funds

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

December 22 - Hedge Funds

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

December 18 - Hedge Funds

13G Filing: RA Capital Management and Scpharmaceuticals Inc (SCPH)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

December 12 - Hedge Funds

13G Filing: RA Capital Management and Inflarx NV (IFRX)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

December 12 - Hedge Funds

13D Filing: RA Capital Management and Wave Life Sciences Ltd (WVE)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

November 20 - Hedge Funds

13G Filing: RA Capital Management and Sunesis Pharmaceuticals Inc (SNSS)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

November 14 - Hedge Funds

13D Filing: RA Capital Management and Kalvista Pharmaceuticals Inc. (KALV)

Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...

Keep Reading →

November 14 - Hedge Funds

13D Filing: RA Capital Management and Dicerna Pharmaceuticals Inc (DRNA)

You can access the original SEC filing by clicking here.

Keep Reading →

April 13 - Hedge Funds

Avexis Inc. (AVXS): RA Capital Management Ups Its Stake

Peter Kolchinsky's RA Capital Management has slightly raised its stake in Avexis Inc. (NASDAQ:AVXS), as per a new Form 13G with the Securities and Exchange Commission.

Keep Reading →

December 27 - Hedge Funds, News

RA Capital Management Slashes Alcobra Ltd (ADHD) Position After FDA Clinical Hold

Peter Kolchinsky's RA Capital Management has slashed its position in Alcobra Ltd (NASDAQ:ADHD) to just under 1.31 million shares according to a new 13G filing with the SEC.

Keep Reading →

October 23 - Hedge Funds, News

Aclaris Therapeutics Inc (ACRS): RA Capital Management Disposes of 1.1 Million Shares

An amended 13G filing with the SEC revealed that Peter Kolchinsky's RA Capital Management has sold around 1.1 million shares of Aclaris Therapeutics Inc (NASDAQ:ACRS), decreasing...

Keep Reading →

October 7 - Hedge Funds, News

Protagonist Therapeutics Inc (PTGX): RA Capital Management Acquires 6.8% Stake

Peter Kolchinsky's RA Capital Management reported via a recent 13G filing with the SEC that it has taken a new position in a company that has recently gone public, Protagonist...

Keep Reading →

August 26 - Hedge Funds, News

Vitae Pharmaceuticals Inc (VTAE): RA Capital Management Ups Its Stake

A recent 13G filing with the SEC revealed that Peter Kolchinsky's RA Capital Management has acquired more shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE), as it currently...

Keep Reading →

August 16 - Hedge Funds, News

Ardelyx (ARDX): RA Capital Management Boosts Stake to 7.7%

Peter Kolchinsky's RA Capital Management has stepped up its interest in Ardelyx Inc. (NASDAQ:ARDX).

Keep Reading →

July 29 - Hedge Funds, News

Peter Kolchinsky Is Betting Big On Achillion Pharmaceuticals, Inc. (ACHN), Wave Life Sciences (WVE) & More Heading Into 2016

Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks.

Keep Reading →

February 25 - Hedge Funds, News

13G Filing: RA Capital Management and Derma Sciences, Inc. (DSCI)

In a new filing with the Securities and Exchange Commission, Peter Kolchinsky's RA Capital Management disclosed a position in Derma Sciences Inc (NASDAQ:DSCI).

Keep Reading →

February 1 - Hedge Funds, News

Dalton Investments Proposes 6-Point Action Plan to Eros, While Eminence Capital Reveals New Stake in This Hotel Operator

The practice of monitoring quarterly 13F filings has become more popular in recent years, which led to several exchange traded funds (ETFs) being launched.

Keep Reading →

November 30 - Hedge Fund Analysis, Hedge Funds, News

Two Activist Plays And Two Biotech Moves You Should Check Out

With hedge funds having submitted their 13F filings for the third quarter, people at Insider Monkey are busy compiling the data necessary to identify the best investment opportunities...

Keep Reading →

November 20 - Hedge Funds, News

Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors

Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare...

Keep Reading →

October 13 - Hedge Funds, News

Is Zogenix A Good Stock To Buy Now?

RA Capital Management, led by Peter Kolchinsky, has disclosed a massive new stake in California-based pharmaceutical company Zogenix, Inc (NASDAQ:ZGNX).

Keep Reading →

October 9 - Hedge Funds, News

Steve Cohen, Peter Kolchinsky Disclose New Stakes In Micro-cap Pharmaceutical Stocks

Steve Cohen’s Point72 Asset Management has initiated a new position in Inotek Pharmaceuticals Corporation (NASDAQ:ITEK).

Keep Reading →

August 25 - Hedge Funds, News

Peter Kolchinsky’s New Top Healthcare Pick And Old Favorites

Peter Kolchinsky's RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30.

Keep Reading →

August 15 - Hedge Fund Analysis, Hedge Funds, News

Ardelyx Inc (ARDX): RA Capital Management Discloses 7.3% Passive Stake

RA Capital Management, led by Peter Kolchinsky, has opened a new position in clinical-stage biopharmaceutical company Ardelyx Inc (NASDAQ:ARDX). A new filing with the U.S.

Keep Reading →

June 7 - Hedge Funds, News

Bitauto Hldg Ltd (ADR) (BITA), Aurinia Pharmaceuticals Inc (AUPH): Tiger Global and RA Capital Disclose Their Latest Moves

In a new filing with the Securities and Exchange Commission, Billionaire Chase Coleman's Tiger Global disclosed slightly reducing its exposure to Bitauto Hldg Ltd (ADR) (NYSE...

Keep Reading →

March 27 - Hedge Funds, News, Tech

Regulus Therapeutics Inc (RGLS), Trevena Inc (TRVN), Juno Therapeutics Inc (JUNO): RA Capital’s Top New Biotech Picks

Peter Kolchinsky’s RA Capital Management filed its latest 13F with the Securities and Exchange Commission in February, and we’ve gone through the data to highlight three of...

Keep Reading →

March 4 - Hedge Funds, News

Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves

Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday.

Keep Reading →

December 15 - Hedge Funds, News

Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.

Keep Reading →

November 3 - Hedge Funds, News

Entegris Inc (ENTG), Dicerna Pharmaceuticals Inc (DRNA): GMT Capital and Deerfield Management Report Their Latest Moves

In two new filings, Thomas E. Claugus' GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG).

Keep Reading →

October 16 - Hedge Funds, News, Tech

CIG Wireless Corp (CIGW), Achillion Pharmaceuticals Inc (ACHN): Jeffrey Tannenbaum And Peter Kolchinsky Disclose Their Latest Moves

CIG Wireless Corp (OTCBB:CIGW), an operator of wireless and broadcast communication towers in the United States, has issued approximately 1.25 million shares to Jeffrey Tannenbaum...

Keep Reading →

October 2 - Hedge Funds, News

Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter Kolchinsky’s Latest Equity Moves

RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares.

Keep Reading →

September 29 - Hedge Funds, News

Achillion Pharmaceuticals, Inc. (ACHN): RA Capital Management Sells Over 2 Million Shares

RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with the U.S.

Keep Reading →

September 24 - Hedge Funds, News

Sunesis Pharmaceuticals, Inc. (SNSS): Ken Griffin’s Citadel Boosts His Stake

Citadel Advisors, a fund managed by Ken Griffin, has disclosed boosting its stake in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS).

Keep Reading →

September 22 - Hedge Funds, News

Achillion Pharmaceuticals, Inc. (ACHN): Peter Kolchinsky’s RA Capital Sells Some More Shares

Peter Kolchinsky's RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million shares of Achillion Pharmaceuticals...

Keep Reading →

September 12 - Hedge Funds, News

RA Capital Management Continues To Unload Achillion Pharmaceuticals, Inc. (ACHN) Stock: Sells Further 835,293 Shares

In a new filing with the U.S.

Keep Reading →

September 4 - Hedge Funds, News

« Older Entries
Hedge Fund Resource Center Hedge Fund Resource Center
  • How to Best Use Insider Monkey to Increase Your Returns
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
  • 6 Things You Didn't Know About Hedge Funds
Hot Topics

Apple (AAPL)

Latest Stock News - Company Profile

Warren Buffett

News & Analysis - Portfolio & Stock Picks

Biggest Insider Purchases & Sales

News & Analysis - Data Screener

Google (GOOG)

Latest Stock News - Company Profile

Microsoft (MSFT)

Latest Stock News - Company Profile

Lists

11 Largest Uranium Producing Countries in the World

11 Largest Uranium Producing Countries in the World

5 Largest Uranium Producing Countries in the World

5 Largest Uranium Producing Countries in the World

12 Cheapest Cigarette Brands in 2026

12 Cheapest Cigarette Brands in 2026

5 Cheapest Cigarette Brands in 2026

5 Cheapest Cigarette Brands in 2026

12 Best Cheap Colognes for Men That Smell Amazing

12 Best Cheap Colognes for Men That Smell Amazing

12 Fastest Declining Economies in the World in 2026

12 Fastest Declining Economies in the World in 2026

5 Fastest Declining Economies in the World in 2026

5 Fastest Declining Economies in the World in 2026

10 Most Popular Stocks on Robinhood in 2026

10 Most Popular Stocks on Robinhood in 2026

25 Countries with the Highest Debt to GDP Ratios

25 Countries with the Highest Debt to GDP Ratios

15 States with the Most Gun Violence in the US

15 States with the Most Gun Violence in the US

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

15 Innovative Healthcare Stocks to Buy According to Analysts

15 Innovative Healthcare Stocks to Buy According to Analysts

9 High Growth Small Cap Stocks That Are Profitable

9 High Growth Small Cap Stocks That Are Profitable

20 Most Profitable Stocks of the Last 20 Years

20 Most Profitable Stocks of the Last 20 Years

15 High Growth Mid-Cap Stocks to Buy

15 High Growth Mid-Cap Stocks to Buy

Top 10 Oncology Stocks to Buy Now

Top 10 Oncology Stocks to Buy Now

10 Best Investments During A Recession

10 Best Investments During A Recession

7 Best Rare Earth Stocks to Buy According to Hedge Funds

7 Best Rare Earth Stocks to Buy According to Hedge Funds

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

11 Best Cancer Stocks to Buy Right Now

11 Best Cancer Stocks to Buy Right Now

40 Most Unfriendly Countries in the World

40 Most Unfriendly Countries in the World

30 Unhappiest Countries in the World in 2025

30 Unhappiest Countries in the World in 2025

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

5 Countries with the Most Beautiful Women in the World

5 Countries with the Most Beautiful Women in the World

20 Countries with the Most Beautiful Women in the World

20 Countries with the Most Beautiful Women in the World

20 US Cities with the Highest Homeless Population Per Capita

20 US Cities with the Highest Homeless Population Per Capita

20 Countries with the Highest Homeless Population

20 Countries with the Highest Homeless Population

12 Countries with the Highest Bond Yields in the World

12 Countries with the Highest Bond Yields in the World

20 Countries with the Most Battle Tanks in the World

20 Countries with the Most Battle Tanks in the World

12 Best Nasdaq Stocks Under $20 to Buy Now

12 Best Nasdaq Stocks Under $20 to Buy Now

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Worst Performing Currencies of 2024

10 Worst Performing Currencies of 2024

15 States with the Best Weed in America

15 States with the Best Weed in America

16 Countries with the Largest Proven Oil Reserves in the World

16 Countries with the Largest Proven Oil Reserves in the World

16 Highest Quality Chocolate Brands in the US

16 Highest Quality Chocolate Brands in the US

20 Countries with the Strongest Armies in the World

20 Countries with the Strongest Armies in the World

Top 13 English Speaking Countries in Asia

Top 13 English Speaking Countries in Asia

20 States with Highest Female to Male Ratio in the US

20 States with Highest Female to Male Ratio in the US

40 Best Places to Visit in Europe Before You Die

40 Best Places to Visit in Europe Before You Die

20 States with the Lowest Life Expectancy in the US

20 States with the Lowest Life Expectancy in the US

25 Cities with the Highest Homeless Population in the World

25 Cities with the Highest Homeless Population in the World

20 Countries With The Best English Accent in The World

20 Countries With The Best English Accent in The World

30 Cities with the Highest Weed Consumption in the US

30 Cities with the Highest Weed Consumption in the US

25 Countries with the Highest Alcohol Consumption per Capita

25 Countries with the Highest Alcohol Consumption per Capita

10 Best Gold Stocks Under $30

10 Best Gold Stocks Under $30

10 Best Genomics Stocks To Buy Right Now

10 Best Genomics Stocks To Buy Right Now

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use FAQ CCPA - Do Not Sell My Information. ©2026 Koala Guide LLC.